-The Hindu Business Line Mumbai/ Bengaluru: As talk of onion imports gains ground, the price rally in the bulb in recent days seems to be ebbing. Wholesale prices of onions across major markets in Maharashtra, such as Lasalgaon, Pimpalgaon and Niphad, have witnessed a decline in the last two days. In Pimpalgaon, where arrivals stood at 2,500 tonnes on Friday, the modal prices dropped by a fifth to Rs. 2,000 per quintal...

-The Indian Express The woes of pulses farmers and traders like Kagi can be put down to all-time-high imports of 6.6 mt (valued at Rs 28,524.05 crore) on top of a record domestic production of 22.4 mt in 2016-17 — made worse by the weak, behind-the-curve policy response whether to do with trade or stockholding restrictions. Agriculture in India has always suffered from lethargic and uncoordinated policy response. And there can be...

-PTI The government has formed a committee in its bid to make drugs more affordable in the country, Parliament was informed on Tuesday. “Government has constituted a committee of joint secretaries for ensuring enhanced affordability, availability and accessibility of drugs for the citizens,” Minister of State for Chemicals and Fertilisers Mansukh L. Mandaviya said in a written reply to Lok Sabha. Elaborating on the terms of reference of the committee, the minister said...

-The Hindu Business Line Industry likely to meet officials today New Delhi: Patients with debilitating knee problems, requiring joint replacement surgeries, would soon regain spring in their steps. The National Pharmaceutical Pricing Authority (NPPA), which capped the prices of coronary stents in February, may cap the prices of knee implants soon. According to a source in the know of the developments, the price of knee implants is likely to be capped with just...

-The Hindu Business Line Policymaking has sensibly shifted away from banning the prescription of brand names More than three months after Prime Minister Narendra Modi fired the salvo on getting doctors to prescribe medicines using their generic names, the discussion seems to be on a slow burner. From the strident position that all doctors will have to prescribe medicines using their generic or chemical names, there appears to be a more reconciled acceptance...